|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/496 | (2006.01) |
| A61K 31/519 | (2013.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/635 | (2013.01) | ||
| A61K 31/635 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/496 | (2013.01) |
| (11) | Number of the document | 3515414 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17851730.6 |
| Date of filing the European patent application | 2017-09-18 | |
| (97) | Date of publication of the European application | 2019-07-31 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/052086 |
| Date | 2017-09-18 |
| (87) | Number | WO 2018/053437 |
| Date | 2018-03-22 |
| (30) | Number | Date | Country code |
| 201662396734 P | 2016-09-19 | US | |
| 201662412720 P | 2016-10-25 | US |
| (72) |
GOLD, Daniel P. , US
|
| (73) |
MEI Pharma, Inc. ,
11455 El Camino Real, Suite 250, San Diego, CA 92130,
US
|
| (54) | COMBINATION THERAPY |
| COMBINATION THERAPY |